Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZG-801 Phase II trial in hyperkalemia
jRCT2080224547Phase 2Completed
- Sponsor
- Zeria Pharmaceutical Co., Ltd.
- Start
- Feb 2019
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in hyperkalemia comparing Patiromer with Placebo (2 arms). Started Feb 2019; status: completed.
02
Drugs
patiromer
03
Conditions
hyperkalemia
Beyond the preview
Go deeper on jRCT2080224547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224547.